Laboratorios Litaphar Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Laboratorios Litaphar General Information

Description

Developer and distributor of genetic and therapeutic pharmaceutical products designed to provide therapeutic products for illnesses related to women. The company's genetic and therapeutic pharmaceutical products provide cure of diseases related to gynecology and obstetrics of prostaglandin analogues, progesterone receptor antagonists and selective modulators of progesterone receptors, enabling women patients to recover from illness and improve their sexuality and vulvar health.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • Loiolabide, 7
  • 20730 Azpeitia
  • Spain
+34 943 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Laboratorios Litaphar Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Laboratorios Litaphar‘s full profile, request access.

Request a free trial

Laboratorios Litaphar Executive Team (1)

Name Title Board Seat Contact Info
Ander Larrañaga General Manager, Business Development
To view Laboratorios Litaphar’s complete executive team members history, request access »